{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T15:10:06Z","timestamp":1752160206496,"version":"3.41.2"},"reference-count":25,"publisher":"IOP Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biomed. Phys. Eng. Express"],"published-print":{"date-parts":[[2025,7,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\n                  <jats:italic>Objective.<\/jats:italic> The equivalent uniform RBE-weighted dose (EUD<jats:sub>RBE<\/jats:sub>) is computed in a model problem for hypofractionated proton therapy for ocular melanoma, considering the depth and dose dependence of the relative biological effectiveness (RBE). <jats:italic>Approach.<\/jats:italic> The EUD<jats:sub>RBE<\/jats:sub> was developed to compare the integrated cell survival in radiotherapy modalities with nonuniform distributions of the RBE and the physical dose. Our simulations of the EUD<jats:sub>RBE<\/jats:sub> in hypofractionated proton radiotherapy are based on the linear quadratic (LQ) cell survival model from which the dose correction to the RBE can be evaluated using the theory of dual radiation action. This theory predicts that the higher LET radiation increases the linear component (<jats:italic>\u03b1<\/jats:italic>) of radiation damage, while the quadratic component (<jats:italic>\u03b2<\/jats:italic>) remains unchanged. The effect of depth dependence of the RBE was derived from a fit to experimental data across various spread-out Bragg peaks (SOBPs) and the distribution of the physical dose was considered uniform. <jats:italic>Main results<\/jats:italic>. There are two competing processes that affect the EUD<jats:sub>RBE<\/jats:sub>: first, the EUD<jats:sub>RBE<\/jats:sub> decreases as the fractional dose increases, and second, the EUD<jats:sub>RBE<\/jats:sub> increases with increasing the relative fraction of tumors treated with high RBE at the distal edge of Bragg peak. Our simulations show that the combined effect of these two processes predicts an increase of the EUD<jats:sub>RBE<\/jats:sub> by 9%\u201312% relative to the physical dose for the fractionation schedule 5\u00a0\u00d7\u00a010 Gy (RBE) assuming a distal tumor margin of 5 mm. <jats:italic>Significance<\/jats:italic>. The increase in the RBE at the end of the proton range largely compensates for the decrease in the RBE for higher fractional proton doses, thus producing the EUD<jats:sub>RBE<\/jats:sub> that does not deviate substantially from the clinically used uniform value of RBE\u00a0=\u00a01.1. The EUD<jats:sub>RBE<\/jats:sub> will enable more optimized proton therapy plans and comparison with other modalities such as eye plaque brachytherapy.<\/jats:p>","DOI":"10.1088\/2057-1976\/adea7d","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:47:57Z","timestamp":1751395677000},"page":"045026","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of equivalent uniform RBE-weighted dose in hypofractionated proton therapy for ocular melanoma"],"prefix":"10.1088","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0320-2885","authenticated-orcid":true,"given":"Pavitra","family":"Ramesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-9699","authenticated-orcid":true,"given":"Alexei V","family":"Trofimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Rengan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5479-1962","authenticated-orcid":true,"given":"Alexei V","family":"Chvetsov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"bpexadea7dbib1","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: report of task group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med. Phys."},{"key":"bpexadea7dbib2","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1002\/mp.13996","article-title":"AAPM recommendations on medical physics practices for ocular plaque brachytherapy: report of task group 221","volume":"47","author":"Thomson","year":"2020","journal-title":"Med. Phys."},{"key":"bpexadea7dbib3","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.ijrobp.2024.06.017","article-title":"PTCOG Ocular statement: expert summary of current practices and future developments in ocular proton therapy","volume":"120","author":"Hrbacek","year":"2024","journal-title":"Int. J. Rad. Oncol. Biol. Phys."},{"key":"bpexadea7dbib4","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1001\/archopht.124.6.838","article-title":"Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy","volume":"124","author":"Conway","year":"2006","journal-title":"Arch Opthalmol."},{"key":"bpexadea7dbib5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijrobp.2019.02.005","article-title":"Corneal substructure dosimetry predicts corneal toxicity in patients with uveal melanoma treated with proton beam therapy","volume":"104","author":"Lee","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"bpexadea7dbib6","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1002\/mp.16767","article-title":"Modernization of safety environment for a dedicated beamline for proton ocular therapy","volume":"50","author":"Jee","year":"2023","journal-title":"Med. Phys."},{"key":"bpexadea7dbib7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0161-6420(99)90456-6","article-title":"Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma","volume":"106","author":"Wilson","year":"1999","journal-title":"Ophthalmology"},{"key":"bpexadea7dbib8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2217\/mmt.15.34","article-title":"Low-dose brachytherapy strategies to treat uveal melanoma: is less more?","volume":"3","author":"Oellers","year":"2016","journal-title":"Melanoma Manag."},{"key":"bpexadea7dbib9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mayocpiqo.2021.10.002","article-title":"Treatment of uveal melanoma with radioactive iodine 125 implant compared with proton beam radiotherapy","volume":"6","author":"Bolling","year":"2022","journal-title":"Mayo Clin Proc Inn Qual Out"},{"key":"bpexadea7dbib10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijrobp.2022.07.017","article-title":"A systematic comparison of dose distributions delivered in 125I plaque brachytherapy and proton radiation therapy for ocular melanoma","volume":"115","author":"Trofimov","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"bpexadea7dbib11","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1002\/mp.13390","article-title":"Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy","volume":"46","author":"Paganetti","year":"2019","journal-title":"Med. Phys."},{"key":"bpexadea7dbib12","doi-asserted-by":"publisher","DOI":"10.1118\/1.4769417","article-title":"Impact of variable RBE on proton fractionation","volume":"40","author":"Dasu","year":"2013","journal-title":"Med. Phys."},{"key":"bpexadea7dbib13","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1002\/mp.16783","article-title":"Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response","volume":"50","author":"Pardo-Montero","year":"2023","journal-title":"Med. Phys."},{"key":"bpexadea7dbib14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2307\/3574835","article-title":"A generalized formulation of dual radiation action","volume":"75","author":"Kellerer","year":"1978","journal-title":"Rad Res."},{"key":"bpexadea7dbib15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0360-3016(98)00364-2","article-title":"The assessment of RBE effects using the concept of biologically effective dose","volume":"43","author":"Dale","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"bpexadea7dbib16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: a concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med. Phys."},{"key":"bpexadea7dbib17","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1118\/1.4932219","article-title":"EUD-based biological optimization for carbon ion therapy","volume":"42","author":"Br\u00fcningk","year":"2015","journal-title":"Med. Phys."},{"key":"bpexadea7dbib18","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1002\/mp.16982","article-title":"Equivalent uniform RBE-weighted dose in eye plaque brachytherapy","volume":"51","author":"Chvetsov","year":"2024","journal-title":"Med. Phys."},{"key":"bpexadea7dbib19","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/aadf24","article-title":"Impact of potentially variable RBE in liver proton therapy","volume":"63","author":"Chen","year":"2018","journal-title":"Phys. Med. Biol."},{"key":"bpexadea7dbib20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/mp.12117","article-title":"Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy","volume":"44","author":"\u00d6d\u00e9n","year":"2017","journal-title":"Med. Phys."},{"key":"bpexadea7dbib21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ijrobp.2007.10.059","article-title":"Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy","volume":"70","author":"Park","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"bpexadea7dbib22","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ac047e","article-title":"Tumor control probability in hypofractionated radiotherapy as a function of total and hypoxic tumor volumes","volume":"66","author":"Chvetsov","year":"2021","journal-title":"Phys. Med. Biol."},{"key":"bpexadea7dbib23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ijrobp.2007.10.050","article-title":"Radiobiologic parameters and local effect model predictions for head-and-neck squamous cell carcinomas exposed to high linear energy transfer ions","volume":"71","author":"Beuve","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"bpexadea7dbib24","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1167\/iovs.03-0151","article-title":"Dose fractionation effects in primary and metastatic human uveal melanoma cell lines","volume":"44","author":"van den Aardweg","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"bpexadea7dbib25","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.oret.2022.05.006","article-title":"A comparison of treatment outcomes after standard dose (70 Gy) versus reduced dose (50 Gy) proton radiation in patients with uveal melanoma","volume":"6","author":"Lane","year":"2022","journal-title":"Ophthalmol. Retina."}],"container-title":["Biomedical Physics &amp; Engineering Express"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/adea7d","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/adea7d\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/adea7d","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/adea7d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/adea7d\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/adea7d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/adea7d\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/adea7d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:40:18Z","timestamp":1752158418000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/adea7d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,7,10]]},"published-print":{"date-parts":[[2025,7,31]]}},"URL":"https:\/\/doi.org\/10.1088\/2057-1976\/adea7d","relation":{},"ISSN":["2057-1976"],"issn-type":[{"type":"electronic","value":"2057-1976"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"Assessment of equivalent uniform RBE-weighted dose in hypofractionated proton therapy for ocular melanoma","name":"article_title","label":"Article Title"},{"value":"Biomedical Physics & Engineering Express","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2025 The Author(s). Published by IOP Publishing Ltd","name":"copyright_information","label":"Copyright Information"},{"value":"2025-03-05","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2025-07-01","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2025-07-10","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}